Sign in to view content

Intravitreal Gene Therapy for Neovascular AMD with ADVM-022: Results of the Phase 1 OPTIC Trial

Dante Joseph Pieramici, MD

Video
Published 2021

Related

Number of Injections and Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER
Carl D. Regillo, MD
Annual Meeting Talks
2020
Study of Comparative Treatments for REtinal Vein Occlusion 2 (SCORE2): Primary Results
Ingrid U. Scott, MD, MPH
Updates from the Field
2017
Suprachoroidally delivered gene therapy via non-viral DNA nanoparticles
Christine Kay, MD
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more